Healthcare refers to the organized provision of medical services and support aimed at maintaining or improving health. It encompasses a wide range of services, including prevention, diagnosis, treatment, rehabilitation, and palliative care for individuals. Healthcare can be delivered through various settings, such as hospitals, clinics, outpatient services, and home care, and involves a variety of professionals, including doctors, nurses, therapists, and technicians.
Healthcare systems may vary significantly from one country to another, influenced by social, economic, and political factors. Generally, healthcare aims to ensure access to necessary medical services for populations, promote wellness, and manage public health. It includes both public health measures, like vaccination programs and health education, and personal medical care.
Essential elements of healthcare include accessibility, quality of care, efficiency, and equity. Healthcare can be publicly funded, privately funded, or a combination of both. The field is constantly evolving, focusing on advancements in medical technology, healthcare policies, and the integration of services to enhance patient outcomes. Overall, healthcare is critical for the well-being of individuals and communities, affecting longevity, quality of life, and overall societal health.
F-star Therapeutics is emerging as an independent biotech company following its $161 million acquisition by invoX Pharma, a subsidiary of Sino Biopharmaceutical. The acquisition faced regulatory challenges, particularly with the…
The pharmaceutical and biotech sectors exhibited resilience amid broad economic turmoil, largely unaffected by sweeping tariffs. Companies like Catalyst Pharmaceuticals and Veeva Systems experienced only minor stock declines, while Amgen…
Small and mid-sized biotech companies are driving a revolution in the pharmaceutical industry, despite challenges in clinical trials and regulatory compliance. The biotech sector is expected to generate $50 trillion…
A significant restructuring is occurring within the U.S. FDA and HHS, affecting thousands of positions and raising concerns about the future of innovative medicine in America. Peter Marks, former director…
U.S. tariffs on India, China, and the European Union are set to reshape the global pharmaceutical landscape, affecting both APIs and finished drug products. The tariffs may lead to increased…
DarwinHealth has been recognized as one of the World's Most Innovative Companies for 2025 by Fast Company, highlighting their pivotal role in advancing cancer treatment. The company leverages the powerful…
Oncolytics Biotech Inc. faces financial challenges, reporting a Q4 2024 net loss of $8 million and declining cash reserves. The company’s flagship oncolytic virus, pelareorep, shows promise in cancer therapeutics,…
Brensocatib, developed by Insmed Inc., is anticipated to revolutionize respiratory care for bronchiectasis patients. The drug has received FDA Priority Review, with a potential market launch in the third quarter…
Edesa Biotech's Financial Turnaround and Strategic Focus Edesa Biotech (NASDAQ:EDSA) recently unveiled its financial results for the fiscal year 2024, showcasing a significant transformation in its approach to drug development.…
Krystal Biotech, a prominent player in the biotech sphere, has shared significant updates regarding their investigational treatment, B-VEC, aimed at tackling dystrophic epidermolysis bullosa (DEB). Recently, the European Medicines Agency…